Concord Medical Extends Share Repurchase Program

Concord Medical CCM today announced that its board of directors has approved the extension of its previously announced share repurchase program, which was set to expire in October 2012. The program was extended until the aggregate value of the Company's repurchases equals $20 million. Since the inception of the program, the Company has repurchased 2,029,506 ADSs, representing 6,088,518 ordinary shares, for an aggregate consideration of $6.9 million (including commissions). See full press release